Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Living donor liver transplantation for patients with hepatitis C virus cirrhosis: Tokyo experience.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - 1 Oct 2005

Sugawara Yasuhiko, Makuuchi Masatoshi

Abstract excerpt

Living donor liver transplantation is an alternative therapeutic option for patients with end-stage HCV cirrhosis because of the cadaveric organ shortage. Preliminary results, however, indicate that live donor grafts might be disadvantageous for HCV patients. Sixty-seven patients underwent living donor liver transplantation for HCV cirrhosis between 1996 and 2004. All the patients preemptively received antiviral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis C
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to Liver Cirrhosis

Share to Liver Transplantation

Share to Living Donors

Share to Ribavirin

Share to Secondary Prevention

Source

Identifiers

PMID: 16234059
DOI: 10.1016/s1542-3565(05)00708-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Living donor liver transplantation for patients with hepatitis C virus cirrhosis: Tokyo experience.PMID 16234059Read ↗

The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C.Semantic proximity Read ↗

Liver transplantation from HCV RNA-positive donors in the era of interferon-free HCV therapeutics: a re-examination of the situation.Semantic proximity Read ↗

Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.Semantic proximity Read ↗

Long-term outcome of hepatitis C virus infection after liver transplantation.Semantic proximity Read ↗

Long-term outcome of hepatitis C infection after bone marrow transplantation.Semantic proximity Read ↗

Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list.Semantic proximity Read ↗

Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients.Semantic proximity Read ↗

Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation.Semantic proximity Read ↗

Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.Semantic proximity Read ↗

Long-term outcome of hepatitis C infection after liver transplantation.Semantic proximity Read ↗

Treatment of patients with hepatitis C virus on the waiting list.Semantic proximity Read ↗

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.